Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.

The Food and Drug Administration (FDA) has approved Breztri Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate; BGF) for the maintenance treatment of asthma in adult and ...

The FDA is moving to speed drug development and review by launching real-time clinical trials, which could mean more options for patients.

Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.

The FDA has accepted the NDA for zipalertinib to treat adult patients with locally advanced or metastatic EGFR exon 20 insertion-mutated NSCLC.

In cystic fibrosis, ETI significantly reduced daily cough frequency and increased physical activity levels in patients aged 12 and older.

The updated guideline also strongly recommends RSV vaccination in adults and adolescents with compromised immunity. RSV ...

Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...

CFTR modulators, especially triple therapy, significantly improve sinonasal inflammation and nasal polyp size in patients with cystic fibrosis.

Race-based medicine continues to negatively impact Black patient populations, advocated Joel Bervell, MD, at RPA 2026.

A new hire at the CDC is drawing backlash from public health experts who worry about his influence in the industry.

Use of Global Lung Function Initiative race-neutral vs race-specific equations was associated with systematically lower z-scores in Black children with BPD.